JTEC (TSE:3446) Beneish M-Score: -2.95 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3446 JTEC Corp TSE:3446
56 GF Score
Price 円1,443.00
GF Value 円2,140.06
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JTEC Beneish M-Score?

JTEC TSE:3446 -2.37% 56 Beneish M-Score is -2.95 as of Jul. 30, 2026. GuruFocus rates TSE:3446 with a GF Score™ of 56/100 and a GF Value™ of 円2,140.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 761 Medical Devices & Instruments companies, JTEC ranks better than 75.95% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.95 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for JTEC's Beneish M-Score or its related term are showing as below:

TSE:3446' s Beneish M-Score Range Over the Past 10 Years
Min: -2.95   Med: -1.97   Max: -0.92
Current: -2.95

During the past 9 years, the highest Beneish M-Score of JTEC was -0.92. The lowest was -2.95. And the median was -1.97.


JTEC Beneish M-Score Historical Data

* Premium members only.

The historical data trend for JTEC's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JTEC Beneish M-Score Chart

JTEC Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -1.57 -1.97 -2.95

JTEC Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.95 0.00 0.00 0.00

TSE:3446 vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, JTEC's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JTEC Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where JTEC's Beneish M-Score falls into.


TSE:3446
56GF Score
JTEC Corp TSE:3446
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JTEC Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of JTEC for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8966+0.528 * 1.018+0.404 * 0.869+0.892 * 0.9578+0.115 * 0.97
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.061313-0.327 * 1.0154
=-2.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was 円690 Mil.
Revenue was 円1,926 Mil.
Gross Profit was 円1,179 Mil.
Total Current Assets was 円1,940 Mil.
Total Assets was 円3,688 Mil.
Property, Plant and Equipment(Net PPE) was 円1,378 Mil.
Depreciation, Depletion and Amortization(DDA) was 円159 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円493 Mil.
Long-Term Debt & Capital Lease Obligation was 円409 Mil.
Net Income was 円60 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円286 Mil.
Total Receivables was 円804 Mil.
Revenue was 円2,010 Mil.
Gross Profit was 円1,253 Mil.
Total Current Assets was 円1,816 Mil.
Total Assets was 円3,568 Mil.
Property, Plant and Equipment(Net PPE) was 円1,339 Mil.
Depreciation, Depletion and Amortization(DDA) was 円149 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円413 Mil.
Long-Term Debt & Capital Lease Obligation was 円447 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(690.086 / 1925.592) / (803.528 / 2010.34)
=0.358376 / 0.399698
=0.8966

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1252.754 / 2010.34) / (1178.776 / 1925.592)
=0.623155 / 0.612163
=1.018

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1939.634 + 1377.95) / 3688.131) / (1 - (1815.729 + 1339.324) / 3567.522)
=0.10047 / 0.115618
=0.869

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1925.592 / 2010.34
=0.9578

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(149.153 / (149.153 + 1339.324)) / (158.744 / (158.744 + 1377.95))
=0.100205 / 0.103302
=0.97

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 1925.592) / (0 / 2010.34)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((409.364 + 493.038) / 3688.131) / ((446.507 + 413.185) / 3567.522)
=0.244677 / 0.240977
=1.0154

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(60.348 - 0 - 286.478) / 3688.131
=-0.061313

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

JTEC has a M-score of -2.95 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.95 mean?
JTEC (TSE:3446) has a Beneish M-Score of -2.95 as of Jul. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on JTEC and its competitors. According to the industry distribution chart, JTEC ranks #183 out of 761 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is JTEC's Beneish M-Score too high?
JTEC's current Beneish M-Score is -2.95. Based on the distribution chart, JTEC ranks #183 out of 761 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JTEC has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #183 out of 761 companies for Beneish M-Score. This places JTEC in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on JTEC and its competitors. JTEC's current Beneish M-Score is -2.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,140.06, compared to a current price of 円1,443.00 — trading 32.6% below its estimated fair value. The current Beneish M-Score is -2.95. JTEC's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For JTEC (TSE:3446), the current Beneish M-Score is -2.95 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JTEC (TSE:3446) Overvalued in 2026?

Based on GuruFocus' analysis, JTEC stock appears to be undervalued. The current stock price of 円1,443.00 is trading 32.6% below its estimated GF Value™ of 円2,140.06. GuruFocus considers JTEC to be Significantly Undervalued.

Key valuation signals for TSE:3446:

  • Beneish M-Score: -2.95
  • GF Value™: 円2,140.06 vs. price of 円1,443.00 (32.6% below fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JTEC Business Description

Address 2-5-38 Saito-Yamabuki, Ibaraki-shi, Osaka, JPN, 567-0086
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
56GF Score

Get the complete analysis for TSE:3446

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,443.00
Price
円2,140.06
GF Value